AMED (Japan Agency for Medical R&D) logo
Program

Strengthening Program for Pharmaceutical Startup Ecosystem

Funds pharmaceutical startups in Japan through development stages with registered venture capital investment.

AMED (Japan Agency for Medical R&D)JapanGrant

This program was established to address Japan's shortage of pharmaceutical startup development funding relative to Europe and the US. It registers venture capital firms specializing in drug discovery and subsidizes pharmaceutical startup companies in the development stage — covering non-clinical, Phase 1, Phase 2, and exploratory clinical trials — with investment by a registered VC as a preconditi…

BiotechMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 17 May 2026Source: www.amed.go.jp